Professor Srivastava has over 30 years of experience in cancer research, his current assignment as a University Distinguished Professor and Chairman Department of Immunotherapeutics and Biotechnology in Texas Tech University Health Sciences Center Abilene,Texas, USA.

He is a renowned Cancer researcher in USA with specific interest in Cancer therapeutics, drug resistance, chemo prevention, and repurposing of drugs, received funding for many of his projects. He has contributed as reviewer, editor and author for many publications on cancer, has several patents, and published over 150 papers in US National health library. He has also received many prestigious awards in the field of cancer research.